Finding hidden tumors during bladder cancer surgery

This trial tests if using blue light during surgery helps remove all cancer in people with high-risk non-muscle invasive bladder cancer. It may lower the chance of the cancer coming back.

This trial tests a new optical probe that gives doctors a clearer view of bladder tumors during cystoscopy. It may help make diagnosis and treatment more accurate.

This study examines whether a simple blood test can detect cancer DNA (circulating tumor DNA, or ctDNA) in patients with a specific type of bladder cancer. Detecting this DNA in blood may help doctors predict how the cancer will behave and guide future treatment decisions.

This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.

This trial is testing whether artificial intelligence (AI) can help surgeons perform a more precise removal of bladder tumors during a procedure called TURBT. It is for people with early-stage bladder cancer that hasn't spread into the muscle layer.

This study uses a special imaging dye that targets a protein called Trop2, which is often found on bladder cancer cells. During your surgery, the dye will help doctors see the cancer more clearly with advanced imaging so they can remove it completely.